A 67-year-old female was admitted to our hospital because of pancytopenia. Forty-six percent of erythroblasts in the bone marrow were ringed sideroblasts. Laboratory findings showed an lgG-K monoclonal gammopathy. She was diagnosed as having sideroblastic anemia associated with multiple myeloma in mosaic (45, X/46, XX/47, XXX) Turner's syndrome. There was no response to therapy. The chromosomal pattern of the patient was varied, and was accompanied by the development of refractory anemia with an excess of blasts from refractory anemia with ringed sideroblast 4 months after presentation. Cytogenetic studies suggested that the abnormal clone was restricted to the monosomic cell line. (Internal Medicine 31: 483-485, 1992) 
Introduction
The most common disorder of gonadal development in females is Turner's syndrome; Extragonadal neoplasia in Turner's syndrome has been sporadically reported (1) (2) (3) . Hematologic neoplasia, however, is very rare in Turner's syndrome. Here, we report a case of refractory anemia with excess of blasts (RAEB) which developed from refractory anemia with ringed sideroblast (RARS) associated with multiple myeloma in Turner's syndrome.
Case Report
A 67-year-old female was admitted to our hospital because of anemia in October 1988. She was diagnosed as having multiple myeloma at a university hospital in May 1984 based on osteoporosis, lgG-K monoclonal gammopathy and increased plasma cells (14.8%) in the marrow. Initial blood findings were as follows: hemoglobin 10.6g/dl, WBC 4.9 x lO9/l, platelet count 329 x 109/l, IgG 3,875mg/dl, IgA 206mg/dl and IgM HOmg/dl. Bence-Jones proteinuria was present. Melphalan was given with a total dose of 84mg over 2 months with the serum IgG level declining to 2,547mg/dl. The patient remained asymptomatic for four years and was seen on a follow-up basis by a local hospital.
In May 1988, hematological evaluation revealed hemoglobin ll.0 g/dl, WBC 4.3 X 109/l and platelet count 90x l09/l. Her height was 127.5cm and she weighed 33.6kg. On physical examination, the positive findings were anemia, a systolic murmur and petechiae of the lower extremities. She did not have a webbed neck. Peripheral blood count showed hemoglobin 5.1g/dl, WBC 2.7x lO9/l (myeloblasts 1%, myelocytes 1%, metamyelocytes 5%, neutrophils 37%, lymphocytes 44%, monocytes 11% and basophils 1%), and platelet count 51 X 109/l. Peripheral blood film revealed 13 nucleated red cells per 100 white cells. Bone marrow aspirate was hypercellular with 4.4% myeloblasts, 1.4% plasma cells and 59.0% erythroblasts. Of erythroblasts, 46% were ringed sideroblasts. The bone marrow smear showed dyserythropoiesis with megaloblastoid cells and dysmyelopoiesis with pseudo-Pelger Huet anomaly. There were increased numbers of small hypolobulated megakaryocytes. Neutrophil alkaline phosphatase score was 282. Laboratory findings were as follows: LDH 369 IU/1, Ca 4.3/mEq/l, Fe 87 /ig/dl and ferritin 390 ng/ml. The serum albumin was 3.9 g/dl, serum immunoglobulin levels were: IgG 2,180mg/dl, IgM 150mg/dl, IgA 240 mg/dl, and an lgG-K monoclonal gammopathy was present without Bence-Jones proteinuria. Vitamin B6 was 3.1ng/ml. Folic acid was 2.4ng/ml. Radiological Fig. 1) . Discussion
In Turner's syndrome with mosaic karyotypes, the presence of a Y chromosome or Y chromosome material is associated with a high incidence of gonadoblastoma and dysgerminoma (4, 5) . A tendency for developing neurogenic tumors has also been suggested in Turner's syndrome, however, the occurrence of other extragonadal tumors is rare (1). The risk of hematologic neoplasia is increased in patients with certain congenital chromosome abnormalities, e.g. , Down's syndrome and Klinefelter's syndrome (6) . A few cases of hematologic neoplasia, such as acute myeloblastic leukemia (1, 7), acute lym phoblastic leukemia (8), chronic lymphocytic leukemia (9) and chronic myelocytic leukemia (10-12), have been reported in Turner's syndrome. To our knowledge, Turner's syndrome accompanied by myelodysplastic syndrome (MDS) and multiple myeloma has not been reported. When the present patient was diagnosed as having sideroblastic anemia, there was no evidence of multiple myeloma, namely the IgM and IgA levels were normal and the number of plasma cells was not increased in the marrow on admission. There have been similar cases describing a lack of evidence of multiple myeloma when sideroblastic anemia associated with multiple myeloma developed into leukemia (13). The reason for this condition is unknown. Whether the association between multiple myeloma and Turner's syndrome is merely coincidental is unclear.
In the present case, it was hypothesized that MDS was caused by the antineoplastic chemotherapy for 
